Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular cicatricial pemphigoid.

Melanie Hingorani1, Susan Lightman

  • 1Department of Ophthalmology, Hinchingbrooke Hospital, Huntingdon, Cambridgeshire, UK. melanie.hingorani@hinchingbrooke.nhs.uk

Current Opinion in Allergy and Clinical Immunology
|September 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing integrated care in ophthalmology: a community case study.

Frontiers in medicine·2024
Same author

Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis.

JAMA ophthalmology·2023
Same author

The first giant cell arteritis hospital quality standards (GHOST).

Eye (London, England)·2023
Same author

Quality standards for the care of people with giant cell arteritis in secondary care.

Rheumatology (Oxford, England)·2023
Same author

Acute posterior multifocal placoid pigment epitheliopathy: clinical presentation and risk of stroke and transient ischaemic attack.

The British journal of ophthalmology·2023
Same author

The role of statins in diabetic retinopathy.

Trends in cardiovascular medicine·2022
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Ocular cicatricial pemphigoid (OCP) is challenging to manage. Research is advancing understanding of its mechanisms, which may lead to better therapies for this autoimmune blistering disease affecting the eyes.

Area of Science:

  • Ophthalmology
  • Immunology
  • Dermatology

Background:

  • Ocular cicatricial pemphigoid (OCP), a subtype of mucous membrane pemphigoid (MMP), is a chronic autoimmune blistering disease.
  • It primarily affects the mucous membranes, with significant ocular involvement leading to vision loss.

Purpose of the Study:

  • To review recent literature (2005-2006) on OCP/MMP with ocular relevance.
  • To assess the content, importance, and advancements in understanding and managing OCP.

Main Methods:

  • Systematic review of published articles from 2005-2006.
  • Analysis of antigenic heterogeneity, clinical variations, and treatment outcomes.

Main Results:

  • Antigenic heterogeneity in MMP/OCP is noted, with emerging links to clinical variations and disease severity.

Related Experiment Videos

  • Younger OCP patients exhibit more severe ocular disease and poorer treatment control.
  • Steroids and cyclophosphamide are supported by good evidence; IVIg shows promise for refractory cases.
  • Ocular reconstruction and osteo-odonto-keratoprosthesis offer surgical options for end-stage disease.

    • Conclusions:

    • OCP remains a difficult condition to manage effectively.
    • Advances in understanding disease mechanisms are crucial for developing future safe and disease-modifying therapies.